CKD-705

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCKD-705
Drug Alias NameCKD-705
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionDopamine beta-hydroxylase inhibitors
TargetsDopamine beta-hydroxylase
Therapy Area/IndicationsAnxiety DisordersHypertensionParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersHypertensionParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A